Table 3 Basic information of patient from the included datasets.

From: A 14-gene gemcitabine resistance gene signature is significantly associated with the prognosis of pancreatic cancer patients

 

E-MTAB-6134 (n = 288)

PACA-CA (n = 214)

PACA-AU* (n = 266)

TCGA (n = 148)

GSE85916 (n = 79)

GSE62452 (n = 65)

Sex

Male

166

128

142

79

NA

NA

Female

122

86

124

69

NA

NA

Age (mean ± SD, years)

NA

65.2 ± 11.0

66.6 ± 10.6

65.0 ± 10.8

NA

NA

Status

Alive

107

34

106

67

22

16

Dead

181

180

160

81

57

49

Follow-up (mean ± SD, Months)

29.8 ± 26.9

22.6 ± 20.8

18.3 ± 13.7

17.5 ± 13.9

28.0 ± 30.5

20.2 ± 16.7

T-stage

T1

12

NA

NA

5

NA

NA

T2

39

NA

3

16

NA

NA

T3

237

NA

4

123

NA

NA

T4

0

NA

NA

3

NA

NA

N-stage

N0

72

NA

5

39

NA

NA

N1

216

NA

1

108

NA

NA

Nx

0

NA

6

1

NA

NA

M-stage

M0

NA

NA

NA

67

NA

NA

M1

NA

NA

NA

4

NA

NA

Mx

NA

NA

NA

77

NA

NA

AJCC stage

I

NA

55

1

12

NA

4

II

NA

89

2

127

NA

44

III

NA

8

NA

3

NA

10

IV

NA

0

NA

4

NA

6

Uncertain

NA

62

NA

2

NA

1

Grade

G1

110

NA

NA

20

NA

2

G2

130

NA

NA

84

NA

32

G3

48

NA

NA

43

NA

29

G4

0

NA

NA

1

NA

1

Gx

0

NA

NA

0

NA

1

  1. *The downloaded data from PACA-AU on T stage, N stage and AJCC stage was not complete and the number represents the available data. NA Not Available.